HistoIndex is partnering with the University of Malaya and Pathomics Health to roll out an integrative diagnostics platform for the holistic analysis of patient tumor biopsies.
The collaboration will focus on co-developing new diagnostic tests and offering existing ones to health care providers and patients in China.
Singapore scientists have analysed the genomes of nearly 3,000 patients to identify genomic signatures associated with higher risk of developing stomach cancer.
Scientists in South Korea have developed a mass spectrometry imaging system to analyze living biological samples at micrometer-level resolution.
Researchers in Japan have developed a nanowire device capable of detecting microscopic levels of molecular markers in urine that may be associated with cancer.
Scientists have developed a method to test for metal ions in both liquid and solid samples using paper and adhesive tape.
An advanced microscope producer in China has developed an artificial intelligence-powered microscope that automatically detects malaria parasites in blood smears.
Computational analysis has helped scientists detect the early warning signs of addictive drinking behavior in rats.
Clearbridge BioMedics is the first Asian biotechnology company to join the CANCER-ID consortium for blood-based biomarker evaluation.